U.S. FDA moves to prevent Pharma from 'gaming' generic drug system

WASHINGTON (Reuters) - The U.S. Food and Drug Administration moved on Wednesday to prevent pharmaceutical companies from "gaming" the system to block or delay entry of generic rivals.